Characteristic | REDD1 expression | Total No. | χ2 | P-value | |
---|---|---|---|---|---|
Negative | Positive | ||||
No. (%) | No. (%) | ||||
Age | 0.508* | ||||
20- | 5(83.3) | 1(16.7) | 6 | ||
30- | 6(60.0) | 4(40.0) | 10 | ||
40- | 37(80.4) | 9(19.6) | 46 | ||
50- | 49(80.3) | 12(19.7) | 61 | ||
60- | 66(85.7) | 11(14.3) | 77 | ||
70- | 19(76.0) | 6(24.0) | 25 | ||
80- | 4(100.0) | 0(0.0) | 4 | ||
Stage | 3.4 | 0.334 | |||
Stage I | 25(75.8) | 8(24.2) | 33 | ||
Stage II | 20(71.4) | 8(28.6) | 28 | ||
Stage III | 115(84.6) | 21(15.4) | 136 | ||
Stage IV | 26(81.3) | 6(18.8) | 32 | ||
Histologic type | 0.043* | ||||
Serous carcinoma | 105(84.0) | 20(16.0) | 125 | ||
Mucinous carcinoma | 6(100.0) | 0(0.0) | 6 | ||
Endometrioid carcinoma | 24(77.4) | 7(22.6) | 31 | ||
Clear cell carcinoma | 7(50.0) | 7(50.0) | 14 | ||
Mixed-type carcinoma | 44(83.0) | 9(17.0) | 53 | ||
Ascites | 3.633 | 0.161 | |||
Yes | 108(78.8) | 29(21.2) | 137 | ||
No | 49(80.3) | 12(19.7) | 61 | ||
Unknown | 29(93.5) | 2(6.5) | 31 | ||
Chemotherapy response | 0.801* | ||||
Completely Responders | 130(81.8) | 29(18.2) | 159 | ||
Partial responders | 34(82.9) | 7(17.1) | 41 | ||
Non responders | 14(73.7) | 5(26.3) | 19 | ||
NC/URa | 8(80.0) | 2(20.0) | 10 | ||
CA125 | 0.750* | ||||
< 500 | 50 (78.1) | 14 (21.9) | 64 | ||
≥ 500 | 54 (83.1) | 11 (16.9) | 65 | ||
Unknown | 82 (82.0) | 18 (18.0) | 100 |